{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:42:30Z","timestamp":1761561750853},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/jcp.0b013e3182900fb3","type":"journal-article","created":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T14:15:49Z","timestamp":1366467349000},"page":"386-390","source":"Crossref","is-referenced-by-count":9,"title":["Interaction Between Novelty Seeking and the Aldehyde Dehydrogenase 2 Gene in Heroin-Dependent Patients"],"prefix":"10.1097","volume":"33","author":[{"given":"Sheng-Yu","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiou-Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian-Sheng","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I Hui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzung Lieh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Kuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Band","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"11","key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat Neurosci"},{"issue":"4","key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrg2536","article-title":"New insights into the genetics of addiction.","volume":"10","author":"Li","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"5","key":"R3-16-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.mp.4000918","article-title":"Dopamine D4 receptor gene (DRD4) is associated with novelty seeking (NS) and substance abuse: the saga continues.","volume":"6","author":"Lusher","year":"2001","journal-title":"Mol Psychiatry"},{"issue":"19","key":"R4-16-20210128","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1073\/pnas.0702029104","article-title":"Gene-gene interaction associated with neural reward sensitivity.","volume":"104","author":"Yacubian","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation.","volume":"5","author":"Wise","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"R6-16-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(00)02309-X","article-title":"3,4- Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.","volume":"868","author":"Lamensdorf","year":"2000","journal-title":"Brain Res"},{"issue":"1","key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/exnr.1996.6379","article-title":"Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinsons disease.","volume":"144","author":"Elsworth","year":"1997","journal-title":"Exp Neurol"},{"issue":"15","key":"R8-16-20210128","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/S0021-9258(18)99864-9","article-title":"Brain Aldehyde dehydrogenase. Localization, purification, and properties.","volume":"241","author":"Erwin","year":"1966","journal-title":"J Biol Chem"},{"issue":"2","key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.1982.tb08653.x","article-title":"Aldehyde dehydrogenases in rat brain. Subcellular distribution and properties.","volume":"38","author":"Pettersson","year":"1982","journal-title":"J Neurochem"},{"issue":"1","key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1172\/JCI113875","article-title":"Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant.","volume":"83","author":"Crabb","year":"1989","journal-title":"J Clin Invest"},{"issue":"2","key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00008571-199204000-00002","article-title":"Pharmacogenetics of alcohol metabolism and alcoholism.","volume":"2","author":"Agarwal","year":"1992","journal-title":"Pharmacogenetics"},{"issue":"3","key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/302540","article-title":"Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism.","volume":"65","author":"Chen","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"4","key":"R13-16-20210128","first-page":"677","article-title":"Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men.","volume":"48","author":"Thomasson","year":"1991","journal-title":"Am J Hum Genet"},{"issue":"1-3","key":"R14-16-20210128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2011.06.008","article-title":"The aldehyde dehydrogenase 2 gene is associated with heroin dependence.","volume":"120","author":"Wang","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.ne.19.030196.001445","article-title":"Physiology of the neurotrophins.","volume":"19","author":"Lewin","year":"1996","journal-title":"Annu Rev Neurosci"},{"issue":"8","key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nn1929","article-title":"Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse.","volume":"10","author":"Graham","year":"2007","journal-title":"Nat Neurosci"},{"issue":"1","key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1385\/NMM:5:1:069","article-title":"Neurotrophic mechanisms in drug addiction.","volume":"5","author":"Bolanos","year":"2004","journal-title":"Neuromolecular Med"},{"issue":"1","key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders.","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-0186(99)00122-9","article-title":"Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).","volume":"36","author":"Mossner","year":"2000","journal-title":"Neurochem Int"},{"issue":"1","key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbr.2008.06.009","article-title":"Effects of serotonin depletion on the hippocampal GRMR and BDNF expression during the stress adaptation.","volume":"195","author":"Zhou","year":"2008","journal-title":"Behav Brain Res"},{"issue":"2","key":"R21-16-20210128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"issue":"1-2","key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molbrainres.2005.07.008","article-title":"Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males.","volume":"140","author":"Cheng","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"issue":"5","key":"R23-16-20210128","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1601-183X.2007.00386.x","article-title":"BDNF variability in opioid addicts and response to methadone treatment: preliminary findings.","volume":"7","author":"de Cid","year":"2008","journal-title":"Genes Brain Behav"},{"issue":"1","key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/sj.mp.4000640","article-title":"Association between Tridimensional Personality Questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT).","volume":"5","author":"Benjamin","year":"2000","journal-title":"Mol Psychiatry"},{"issue":"2","key":"R25-16-20210128","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/comp.2002.30797","article-title":"Cloningers Tridimensional Personality Questionnaire: psychometric properties and construct validity in Taiwanese adults.","volume":"43","author":"Chen","year":"2002","journal-title":"Compr Psychiatry"},{"issue":"4800","key":"R26-16-20210128","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1126\/science.2882604","article-title":"Neurogenetic adaptive mechanisms in alcoholism.","volume":"236","author":"Cloninger","year":"1987","journal-title":"Science"},{"issue":"6","key":"R27-16-20210128","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archpsyc.1987.01800180093014","article-title":"A systematic method for clinical description and classification of personality variants. A proposal.","volume":"44","author":"Cloninger","year":"1987","journal-title":"Arch Gen Psychiatry"},{"issue":"3-4","key":"R28-16-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000182892","article-title":"Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits.","volume":"58","author":"Frustaci","year":"2008","journal-title":"Neuropsychobiology"},{"issue":"12","key":"R29-16-20210128","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/sj.npp.1301383","article-title":"Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits.","volume":"32","author":"Hunnerkopf","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"R30-16-20210128","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/sj.npp.1300703","article-title":"BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects.","volume":"30","author":"Jiang","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"R31-16-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00406-011-0189-3","article-title":"BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects.","volume":"261","author":"Minelli","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"7","key":"R33-16-20210128","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview: the schedule for affective disorders and schizophrenia.","volume":"35","author":"Endicott","year":"1978","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"R34-16-20210128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.ALC.0000117832.62901.61","article-title":"Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence.","volume":"28","author":"Huang","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"R35-16-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/mcpr.1995.0030","article-title":"The frequency of the mitochondrial aldehyde dehydrogenase I2 (atypical) allele in Caucasian, Oriental and African black populations determined by the restriction profile of PCR-amplified DNA.","volume":"9","author":"Dandre","year":"1995","journal-title":"Mol Cell Probes"},{"issue":"3","key":"R36-16-20210128","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/342288","article-title":"The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.","volume":"71","author":"Neves-Pereira","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"4","key":"R38-16-20210128","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1073\/pnas.90.4.1247","article-title":"Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase.","volume":"90","author":"Keung","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"R39-16-20210128","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1530-0277.2009.00898.x","article-title":"Association between personality traits and ALDH2 polymorphism in Japanese male alcoholics.","volume":"33","author":"Kimura","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"R40-16-20210128","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.comppsych.2009.11.008","article-title":"Association between Novelty Seeking of opiate-dependent patients and the catechol-O-methyltransferase Val(158)Met polymorphism.","volume":"51","author":"Demetrovics","year":"2010","journal-title":"Compr Psychiatry"},{"issue":"2","key":"R41-16-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1207\/s15327752jpa5302_4","article-title":"The relationship of MMPI and Sensation Seeking Scales to adolescent drug use.","volume":"53","author":"Andrucci","year":"1989","journal-title":"J Pers Assess"},{"issue":"1-2","key":"R42-16-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0166-4328(95)00203-0","article-title":"Psychobiology of novelty seeking and drug seeking behavior.","volume":"77","author":"Bardo","year":"1996","journal-title":"Behav Brain Res"},{"issue":"2","key":"R43-16-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugalcdep.2003.10.006","article-title":"Personality profile and drug of choice; a multivariate analysis using Cloningers TCI on heroin addicts, alcoholics, and a random population group.","volume":"73","author":"Le Bon","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"R44-16-20210128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1037\/0022-3514.74.2.387","article-title":"Temperament and novelty seeking in adolescent substance use: convergence of dimensions of temperament with constructs from Cloningers theory.","volume":"74","author":"Wills","year":"1998","journal-title":"J Pers Soc Psychol"},{"issue":"2","key":"R45-16-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0447.2005.00546.x","article-title":"Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates.","volume":"112","author":"Cohen","year":"2005","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"R46-16-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0899-3289(00)00031-6","article-title":"Neuroendocrine correlates of temperament traits in abstinent opiate addicts.","volume":"11","author":"Gerra","year":"2000","journal-title":"J Subst Abuse"},{"key":"R47-16-20210128","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0191-8869(98)00008-7","article-title":"Validation of the German version of Cloningers TPQ: replication and correlations with stress coping, mood measures and drug use.","volume":"24","author":"Krebs","year":"1998","journal-title":"Pers Individ Differ"},{"key":"R48-16-20210128","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0191-8869(95)00128-X","article-title":"Reliability and construct validity of the German version of Cloningers Tridimensional Personality Questionnaire.","volume":"19","author":"Weyers","year":"1995","journal-title":"Pers Individ Differ"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182900fb3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:01:27Z","timestamp":1620957687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201306000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182900fb3","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}